Search results
Showing results for
Respiratory Syncytial Virus (RSV) is one of the most common reasons for young infants to be admitted to hospital, and globally is second only to malaria as a cause of death in infants between 1 and 12 months of age. In the UK it mostly occurs from October to February, causing a wave of infections that stretch the capacity of children’s wards to their limits.
Daniel O'Connor
BSc AFHEA MSc DPhil (OXON) Daniel O'Connor - Associate Professor | Head of Bioinformatics
Robert Shaw
MA (Cantab), MSci (Cantab), MBBS (Imp), MRCP (UK), DPhil (Oxon) Robert Shaw - Senior Vaccine Clinical Trials Physician
Yama G.Farooq
BCA Computer Application , MSc in Information Technology and Software Engineering Yama G.Farooq - Programming and Data Management Director
Stephane Paulus
MD, DTM&H, FRCPCH Stephane Paulus - Consultant in Paediatric Infectious Diseases
Sir Andrew Pollard
BSc MBBS PhD (Lond), DIC, MRCP (UK), FHEA, FRCPCH, MA, FMedSci, FRS Sir Andrew Pollard - Ashall Professor of Infection & Immunity
Emma Plested
Emma Plested - Programme and Regulatory Affairs Director (UK)
Parvinder Aley
OBE, PhD Parvinder Aley - Director of Global Operations (OVG)

